Hyperkalemia is a potentially life-threatening side effect of RAASi use. Individuals with heart failure are particularly susceptible because heart failure itself can cause hyperkalemia. “Several ...

Please provide your email address to receive an email when new articles are posted on . Between 11% and 17% of patients with chronic kidney disease developed chronic hyperkalemia, which was more ...

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent ...